NM_002055.5:c.140C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002055.5(GFAP):​c.140C>T​(p.Pro47Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00682 in 1,612,262 control chromosomes in the GnomAD database, including 47 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P47P) has been classified as Benign.

Frequency

Genomes: 𝑓 0.0053 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0070 ( 45 hom. )

Consequence

GFAP
NM_002055.5 missense

Scores

4
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9O:1

Conservation

PhyloP100: 2.09

Publications

13 publications found
Variant links:
Genes affected
GFAP (HGNC:4235): (glial fibrillary acidic protein) This gene encodes one of the major intermediate filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]
GFAP Gene-Disease associations (from GenCC):
  • Alexander disease
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • Alexander disease type II
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006749183).
BP6
Variant 17-44915347-G-A is Benign according to our data. Variant chr17-44915347-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 66457.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00532 (810/152348) while in subpopulation NFE AF = 0.00955 (650/68040). AF 95% confidence interval is 0.00894. There are 2 homozygotes in GnomAd4. There are 376 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 810 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GFAPNM_002055.5 linkc.140C>T p.Pro47Leu missense_variant Exon 1 of 9 ENST00000588735.3 NP_002046.1
GFAPNM_001363846.2 linkc.140C>T p.Pro47Leu missense_variant Exon 1 of 10 NP_001350775.1
GFAPNM_001242376.3 linkc.140C>T p.Pro47Leu missense_variant Exon 1 of 7 NP_001229305.1
GFAPNM_001131019.3 linkc.140C>T p.Pro47Leu missense_variant Exon 1 of 8 NP_001124491.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GFAPENST00000588735.3 linkc.140C>T p.Pro47Leu missense_variant Exon 1 of 9 1 NM_002055.5 ENSP00000466598.2

Frequencies

GnomAD3 genomes
AF:
0.00532
AC:
810
AN:
152230
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00268
Gnomad ASJ
AF:
0.00749
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000827
Gnomad FIN
AF:
0.00235
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00955
Gnomad OTH
AF:
0.00574
GnomAD2 exomes
AF:
0.00493
AC:
1230
AN:
249678
AF XY:
0.00484
show subpopulations
Gnomad AFR exome
AF:
0.00126
Gnomad AMR exome
AF:
0.00307
Gnomad ASJ exome
AF:
0.00838
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00334
Gnomad NFE exome
AF:
0.00781
Gnomad OTH exome
AF:
0.00393
GnomAD4 exome
AF:
0.00697
AC:
10180
AN:
1459914
Hom.:
45
Cov.:
31
AF XY:
0.00680
AC XY:
4934
AN XY:
725886
show subpopulations
African (AFR)
AF:
0.000837
AC:
28
AN:
33464
American (AMR)
AF:
0.00293
AC:
131
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.00796
AC:
208
AN:
26120
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39666
South Asian (SAS)
AF:
0.00145
AC:
125
AN:
86226
European-Finnish (FIN)
AF:
0.00305
AC:
162
AN:
53096
Middle Eastern (MID)
AF:
0.00244
AC:
14
AN:
5736
European-Non Finnish (NFE)
AF:
0.00821
AC:
9114
AN:
1110616
Other (OTH)
AF:
0.00658
AC:
397
AN:
60300
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
564
1128
1691
2255
2819
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
330
660
990
1320
1650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00532
AC:
810
AN:
152348
Hom.:
2
Cov.:
32
AF XY:
0.00505
AC XY:
376
AN XY:
74506
show subpopulations
African (AFR)
AF:
0.00120
AC:
50
AN:
41566
American (AMR)
AF:
0.00268
AC:
41
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00749
AC:
26
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000828
AC:
4
AN:
4830
European-Finnish (FIN)
AF:
0.00235
AC:
25
AN:
10624
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00955
AC:
650
AN:
68040
Other (OTH)
AF:
0.00568
AC:
12
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
39
79
118
158
197
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00696
Hom.:
2
Bravo
AF:
0.00470
TwinsUK
AF:
0.00863
AC:
32
ALSPAC
AF:
0.00597
AC:
23
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.0101
AC:
87
ExAC
AF:
0.00502
AC:
609
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00731
EpiControl
AF:
0.00682

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:6Other:1
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Epithelial Biology; Institute of Medical Biology, Singapore
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 08, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

GFAP: BS2 -

Dec 29, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Dec 29, 2023
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Feb 14, 2022
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Alexander disease Benign:1
May 28, 2019
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Uncertain
-0.040
CADD
Uncertain
24
DANN
Benign
0.80
DEOGEN2
Benign
0.29
.;T;.;.;.;T;.;.;.
Eigen
Benign
-0.29
Eigen_PC
Benign
-0.18
FATHMM_MKL
Benign
0.72
D
LIST_S2
Uncertain
0.92
D;D;D;D;D;D;D;D;D
MetaRNN
Benign
0.0067
T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.52
T
MutationAssessor
Benign
2.0
.;M;.;M;M;.;.;.;.
PhyloP100
2.1
PrimateAI
Uncertain
0.74
T
PROVEAN
Benign
-0.61
.;.;N;N;.;.;.;.;.
REVEL
Uncertain
0.49
Sift
Benign
0.34
.;.;T;T;.;.;.;.;.
Sift4G
Benign
0.17
.;.;T;T;.;T;T;.;.
Polyphen
0.021
.;B;.;.;.;.;.;.;.
Vest4
0.39, 0.41
MVP
0.95
MPC
0.60
ClinPred
0.019
T
GERP RS
4.8
PromoterAI
-0.0068
Neutral
Varity_R
0.19
gMVP
0.70
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs57474185; hg19: chr17-42992715; API